KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 117 | 110 | −7 |
| Shares | 23.6M | 24.3M | +732.6K (+3.1%) |
| Value | $605.1M | $582.7M | −$22.4M (−3.7%) |
New holders (18)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prosight Management, LP | 181,171 | $4.34M | 2.75% |
| Invesco Ltd. | 155,840 | $3.73M | 0.00% |
| Nan Fung Group Holdings Ltd | 78,720 | $1.89M | 0.59% |
| Aristides Capital LLC | 23,000 | $551.0K | 0.42% |
| Los Angeles Capital Management LLC | 20,079 | $481.0K | 0.00% |
| New York Life Investments Alternatives | 13,760 | $330.0K | 0.22% |
| Legato Capital Management LLC | 12,903 | $309.0K | 0.04% |
| Alliancebernstein L.P. | 12,200 | $292.0K | 0.00% |
| Jane Street Group, LLC | 12,179 | $292.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 9,695 | $232.0K | 0.00% |
| Virtus ETF Advisers LLC | 7,893 | $189.0K | 0.08% |
| Acadian Asset Management LLC | 6,002 | $144.0K | 0.00% |
| Nisa Investment Advisors, LLC | 2,400 | $58.0K | 0.00% |
| US Bancorp | 113 | $3.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 99 | $2.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 59 | $1.00K | 0.00% |
| Captrust Financial Advisors | 41 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 45 | $1.00K | 0.00% |
Sold out (25)
Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.